(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

In today’s CEO Daily: Diane Brady talks to GoodRx CEO Wendy Barnes. The big story: Trump, Putin, and Zelensky headed for ...

But with GLP-1 list prices exceeding $1,000 a month, most employers have declined to cover the drugs for weight loss—leaving roughly 100 million beneficiaries to look for ways to pay themselves.

The list prices of Ozempic and similar drugs have started to drop as of late; for instance, America’s upstairs neighbor Canada is expected to approve the first generics of Ozempic early next ...

Medicare coverage for GLP-1s for obesity could cost $35 billion from 2026 to 2034. Annual treatment with GLP-1 drugs costs between $5,000 and $7,000 per person. This simple system has nailed 1,000 ...